Free Trial

Wellington Management Group LLP Boosts Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Sabra Health Care REIT logo with Finance background

Wellington Management Group LLP grew its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 33.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,205,042 shares of the real estate investment trust's stock after buying an additional 808,207 shares during the period. Wellington Management Group LLP owned 1.35% of Sabra Health Care REIT worth $55,511,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in SBRA. Principal Financial Group Inc. boosted its position in Sabra Health Care REIT by 2.5% in the fourth quarter. Principal Financial Group Inc. now owns 22,109,683 shares of the real estate investment trust's stock valued at $382,940,000 after buying an additional 536,247 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Sabra Health Care REIT by 4.3% in the 4th quarter. JPMorgan Chase & Co. now owns 10,312,991 shares of the real estate investment trust's stock valued at $178,621,000 after acquiring an additional 426,074 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Sabra Health Care REIT by 1.4% in the fourth quarter. Geode Capital Management LLC now owns 6,381,525 shares of the real estate investment trust's stock worth $110,550,000 after acquiring an additional 86,727 shares during the period. Northern Trust Corp raised its holdings in shares of Sabra Health Care REIT by 27.7% during the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after purchasing an additional 905,466 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Sabra Health Care REIT by 13.0% during the fourth quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock valued at $69,967,000 after purchasing an additional 463,601 shares during the period. Hedge funds and other institutional investors own 99.40% of the company's stock.

Sabra Health Care REIT Price Performance

Shares of SBRA traded down $0.03 during mid-day trading on Tuesday, hitting $17.45. 644,002 shares of the company were exchanged, compared to its average volume of 2,213,450. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. Sabra Health Care REIT, Inc. has a 1-year low of $13.87 and a 1-year high of $20.03. The stock has a market cap of $4.15 billion, a price-to-earnings ratio of 32.93, a price-to-earnings-growth ratio of 1.97 and a beta of 0.88. The company has a 50 day moving average of $17.54 and a 200-day moving average of $17.31.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.01. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The business had revenue of $183.54 million for the quarter, compared to the consensus estimate of $180.23 million. During the same quarter last year, the business posted $0.35 earnings per share. The business's quarterly revenue was up 10.1% compared to the same quarter last year. Analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.88%. The ex-dividend date of this dividend was Friday, May 16th. Sabra Health Care REIT's payout ratio is currently 203.39%.

Insider Buying and Selling

In related news, Director Michael J. Foster sold 11,000 shares of the business's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the sale, the director now directly owns 64,725 shares in the company, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have weighed in on SBRA. Scotiabank lifted their price objective on Sabra Health Care REIT from $18.00 to $19.00 and gave the company a "sector perform" rating in a research note on Monday, May 12th. Truist Financial increased their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $19.50.

Get Our Latest Stock Analysis on SBRA

Sabra Health Care REIT Company Profile

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Read More

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Healthcare REIT Right Now?

Before you consider Sabra Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.

While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines